Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pim

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Oncogene|December 22, 1999
HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6D Pim, L Banks
Oncogene|April 1, 1991
Loss of HPV-16 E7 dependence in cells transformed by HPV-16 E7 plus EJ-ras correlates with increased c-myc expressionD Pim, L Banks
The EMBO Journal|January 1, 1982
Radioimmunoassay of the cellular protein p53 in mouse and human cell linesS Benchimol, D Pim, L Crawford
The Journal of General Virology|February 12, 1998
Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activityP Massimi, D Pim, L Banks
Oncogene|January 1, 1992
Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptorD Pim, M Collins, L Banks
Oncogene|July 17, 1997
Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growthD Pim, P Massimi, L Banks
Oncogene|January 5, 2000
The role of the E6-p53 interaction in the molecular pathogenesis of HPVM Thomas, D Pim, L Banks
Oncogene Research|June 1, 1987
Alternative splicing of human p53 transcriptsG Matlashewski, D Pim, L Banks, et al.
Molecular and Cellular Biochemistry|February 6, 2002
Regulation of the human papillomavirus oncoproteins by differential phosphorylationP Massimi, D Pim, C Kühne, et al.
Oncogene|July 18, 1996
Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradationM Thomas, G Matlashewski, D Pim, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Oncogene|December 22, 1999
HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6D Pim, L Banks
Oncogene|April 1, 1991
Loss of HPV-16 E7 dependence in cells transformed by HPV-16 E7 plus EJ-ras correlates with increased c-myc expressionD Pim, L Banks
The EMBO Journal|January 1, 1982
Radioimmunoassay of the cellular protein p53 in mouse and human cell linesS Benchimol, D Pim, L Crawford
The Journal of General Virology|February 12, 1998
Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activityP Massimi, D Pim, L Banks
Oncogene|January 1, 1992
Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptorD Pim, M Collins, L Banks
Oncogene|July 17, 1997
Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growthD Pim, P Massimi, L Banks
Oncogene|January 5, 2000
The role of the E6-p53 interaction in the molecular pathogenesis of HPVM Thomas, D Pim, L Banks
Oncogene Research|June 1, 1987
Alternative splicing of human p53 transcriptsG Matlashewski, D Pim, L Banks, et al.
Molecular and Cellular Biochemistry|February 6, 2002
Regulation of the human papillomavirus oncoproteins by differential phosphorylationP Massimi, D Pim, C Kühne, et al.
Oncogene|July 18, 1996
Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradationM Thomas, G Matlashewski, D Pim, et al.
Pageof 3